首页> 美国卫生研究院文献>Stem Cells Translational Medicine >In Vivo Formation of Stable Hyaline Cartilage by Naïve Human Bone Marrow Stromal Cells with Modified Fibrin Microbeads
【2h】

In Vivo Formation of Stable Hyaline Cartilage by Naïve Human Bone Marrow Stromal Cells with Modified Fibrin Microbeads

机译:修饰纤维蛋白微珠的幼稚人骨髓基质细胞在体内形成稳定的透明软骨。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Osteoarthritic and other types of articular cartilage defects never heal on their own. Medicinal and surgical approaches are often ineffective, and the supply of autologous chondrocytes for tissue engineering is very limited. Bone marrow stromal cells (BMSCs, also known as bone marrow‐derived mesenchymal stem cells) have been suggested as an adequate cell source for cartilage reconstruction. However, the majority of studies employing BMSCs for cartilage tissue engineering have used BMSCs predifferentiated into cartilage prior to implantation. This strategy has failed to achieve formation of stable, hyaline‐like cartilage, resistant to hypertrophy in vivo. We hypothesized that in vitro predifferentiation of BMSCs is not necessary when cells are combined with an adequate scaffold that supports the formation of stable cartilage in vivo. In this study, naïve (undifferentiated) human BMSCs were attached to dehydrothermally crosslinked stable fibrin microbeads (FMBs) without and with other scaffolds and implanted subcutaneously into immunocompromised mice. Optimal formation of abundant, hypertrophy‐resistant, ectopic hyaline‐like cartilage was achieved when BMSCs were attached to FMBs covalently coated with hyaluronic acid. The cartilage that was formed was of human origin and was stable for at least 28 weeks in vivo. stem cells translational medicine 2019;8:586–592
机译:骨关节炎和其他类型的关节软骨缺损永远无法自行治愈。药物和手术方法通常无效,并且用于组织工程的自体软骨细胞的供应非常有限。骨髓基质细胞(BMSC,又称骨髓来源的间充质干细胞)被认为是软骨重建的合适细胞来源。但是,大多数将BMSC用于软骨组织工程的研究都使用BMSC在植入前预先分化为软骨。该策略未能实现形成稳定的,透明状的,对体内肥大有抵抗力的软骨。我们假设当细胞与支持体内稳定软骨形成的适当支架相结合时,BMSC的体外预分化是不必要的。在这项研究中,将未分化的未分化人类骨髓间充质干细胞(BMSCs)与无支架或无支架的脱氢热交联的稳定纤维蛋白微珠(FMBs)连接,并皮下植入免疫受损的小鼠体内。当将BMSCs连接到共价透明质酸包被的FMB上时,可以最佳地形成丰富的,肥厚的,异位的透明质酸样软骨。形成的软骨是人类起源的,并且在体内至少稳定28周。干细胞转化医学2019; 8:586–592

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号